BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Nov 27, 2026; 18(11): 123786
Published online Nov 27, 2026. doi: 10.4240/wjgs.123786
Table 2 Clinically relevant characteristics according to residual-stone status, n (%)/median (interquartile range)
Item
Overall (n = 300)
Non-residual stone group (n = 218)
Residual stone group (n = 82)
P value
Baseline characteristics
Age (years)58.00 (51.00-66.00) 58.00 (52.00-66.00) 56.50 (50.00-65.00)0.401
Sex0.428
Male101 (33.67) 70 (32.11) 31 (37.80)
Female199 (66.33) 148 (67.89) 51 (62.20)
BMI22.04 (19.94-24.22) 22.22 (19.98-24.41) 21.34 (19.55-23.56)0.195
Symptoms
Abdominal pain 229 (76.33) 161 (73.85) 68 (82.93) 0.135
Nausea and vomiting 71 (23.67) 46 (21.10) 25 (30.49) 0.121
Fever 72 (24.00) 46 (21.10) 26 (31.71) 0.078
Jaundice 27 (9.00) 19 (8.72) 8 (9.76) 0.957
HBV infection34 (11.33) 23 (10.55) 11 (13.41) 0.622
Diabetes 43 (14.33) 24 (11.01) 19 (23.17) 0.013
Hypertension 49 (16.33) 39 (17.89) 10 (12.20) 0.311
Previous surgical history
Cholecystectomy 114 (38.00) 77 (35.32) 37 (45.12) 0.154
Choledochoscopy64 (21.33) 45 (20.64) 19 (23.17) 0.750
Cholangioenterostomy 19 (6.33) 14 (6.42) 5 (6.10) 1.000
Partial hepatectomy 14 (4.67) 8 (3.67) 6 (7.32) 0.304
Stone classification10.289
Type I 34 (11.33) 28 (12.84) 6 (7.32)
Type IIa 54 (18.00) 39 (17.89) 15 (18.29)
Type IIb 48 (16.00) 39 (17.89) 9 (10.98)
Type IIc10 (3.33) 7 (3.21) 3 (3.66)
Type E154 (51.33) 105 (48.17) 49 (59.76)
Disease duration (months)1.50 (0.50-12.00) 1.50 (0.50-12.00) 1.50 (0.50-21.00) 0.625
Imaging
Gallstones77 (25.67)58 (26.61)19 (23.17)0.646
Cholangitis117 (39.00)79 (36.24)38 (46.34)0.143
Liver abscess44 (14.67)27 (12.39)17 (20.73)0.101
Liver atrophy104 (34.67)74 (33.94)30 (36.59)0.770
Liver cirrhosis23 (7.67)12 (5.50)11 (13.41)0.040
Biliary stricture79 (26.33)33 (23.24)46 (29.11)0.307
Biliary dilation282 (94.00)205 (94.04)77 (93.90)1.000
Stone location< 0.001
Unilateral225 (75.00)183 (83.94)42 (51.22)
Bilateral75 (25.00)35 (16.06)40 (48.78)
Intraoperative characteristics
Surgical method0.486
OH142 (47.33)100 (45.87)42 (51.22)
LH158 (52.67)118 (54.13)40 (48.78)
Operative time (minutes)295.00 (230.75-335.00)280.00 (219.25-322.75)335.00 (305.50-404.00)< 0.001
Intraoperative blood loss (mL)300.00 (200.00-500.00)300.00 (200.00-500.00)400.00 (200.00-600.00)0.009
Intraoperative blood transfusion26 (8.67)17 (7.80)9 (10.98)0.521
ASA classification0.505
I205 (68.33)146 (66.97)59 (71.95)
II93 (31.00)71 (32.57)22 (26.83)
III2 (0.67)1 (0.46)1 (1.22)
Number of pringle maneuvers0.220
≤ 3215 (71.67)161 (73.85)54 (65.85)
> 385 (28.33)57 (26.15)28 (34.15)
Liver resection extent0.202
Left158 (52.67)118 (54.13)40 (48.78)
Left lateral71 (23.67)55 (25.23)16 (19.51)
Right34 (11.33)20 (9.17)14 (17.07)
Right posterior15 (5.00)8 (3.67)7 (8.54)
Left medial lobe + right anterior5 (1.67)4 (1.83)1 (1.22)
Right anterior3 (1.00)3 (1.38)0 (0.00)
Others214 (4.67)10 (4.59)4 (4.88)
Other related procedures
Cholecystectomy136 (45.33)97 (44.50)39 (47.56)0.730
Choledochoenterostomy90 (30.00)61 (27.98)29 (35.37)0.270
T-tube drainage210 (70.00)168 (77.06)42 (51.22)< 0.001
Postoperative complications
Anastomotic stenosis30 (10.00)16 (7.34)14 (17.07)0.022
Postoperative biliary stricture56 (18.67)20 (9.17)36 (43.90)< 0.001
Abdominal infection23 (7.67)17 (7.80)6 (7.32)1.000
Pulmonary infection93 (31.00)71 (32.57)22 (26.83)0.413
Incision infection12 (4.00)7 (3.21)5 (6.10)0.420
Abdominal hemorrhage8 (2.67)5 (2.29)3 (3.66)0.801
Intestinal obstruction6 (2.00)3 (1.38)3 (3.66)0.426
Positive pathogen culture
Bile57 (19.00)32 (14.68)25 (30.49)0.003
Peritoneal drainage fluid27 (9.00)14 (6.42)13 (15.85)0.020
Blood32 (10.67)21 (9.63)11 (13.41)0.462
Bile leakage38 (12.67)16 (7.34)22 (26.83)< 0.001
Intestinal leakage11 (3.67)4 (1.83)7 (8.54)0.016


Write to the Help Desk